Company Filing History:
1 out of 38 
1 out of 6 
1 out of 8 Years Active: 2019
Title: Alejandro López González: Innovator in Myotonic Dystrophy Treatment
Introduction
Alejandro López González is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of medical research, particularly in the treatment of myotonic dystrophy. His innovative work has led to the development of a unique compound aimed at addressing this challenging condition.
Latest Patents
Alejandro holds a patent for "Compounds for the treatment of myotonic dystrophy." This invention relates to a compound of formula (I), provided that this compound is not caffeine, for use in the treatment of myotonic dystrophy type 1 and type 2. The patent also encompasses compositions comprising the compound of formula (I) and introduces new compounds that are dimers of compounds of formula (I). He has 1 patent to his name.
Career Highlights
Throughout his career, Alejandro has worked with esteemed institutions such as Universitat de València and Institut Químic de Sarrià CETS Fundació Privada. His experience in these organizations has allowed him to further his research and contribute to advancements in medical science.
Collaborations
Alejandro has collaborated with notable colleagues, including Ruben Artero Allepuz and Josep Castells Boliart. These partnerships have enriched his research and fostered innovation in the field.
Conclusion
Alejandro López González is a dedicated inventor whose work in developing treatments for myotonic dystrophy showcases his commitment to improving patient outcomes. His contributions to medical research are invaluable and highlight the importance of innovation in healthcare.